Compile Data Set for Download or QSAR
Report error Found 321 Enz. Inhib. hit(s) with all data for entry = 680
LigandPNGBDBM286570(US9566312, Compound 2.8.9)
Affinity DataKd:  0.300nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM50030493(CHEMBL3344501 | US9566312, Compound 2.17.4)
Affinity DataKd:  0.300nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286607(US9566312, Compound 2.19.3)
Affinity DataKd:  0.300nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286615(US9566312, Compound 2.20.2)
Affinity DataKd:  0.300nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286583(US9566312, Compound 2.17.1)
Affinity DataKd:  0.300nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286543(US9566312, Compound 2.5.24)
Affinity DataKd:  0.300nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286543(US9566312, Compound 2.5.24)
Affinity DataKd:  0.300nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286568(US9566312, Compound 2.8.7)
Affinity DataKd:  0.300nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286528(US9566312, Compound 2.5.9)
Affinity DataKd:  0.300nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286569(US9566312, Compound 2.8.8)
Affinity DataKd:  0.300nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286585(US9566312, Compound 2.17.3)
Affinity DataKd:  0.300nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286566(US9566312, Compound 2.8.5)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286582(US9566312, Compound 2.16)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286607(US9566312, Compound 2.19.3)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286583(US9566312, Compound 2.17.1)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286608(US9566312, Compound 2.19.4)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286608(US9566312, Compound 2.19.4)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286568(US9566312, Compound 2.8.7)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286531(US9566312, Compound 2.5.12)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286613(US9566312, Compound 2.19.9)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286613(US9566312, Compound 2.19.9)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286573(US9566312, Compound 2.9)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286587(US9566312, Compound 2.17.5)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286596(US9566312, Compound 2.17.14)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286612(US9566312, Compound 2.19.8)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286555(US9566312, Compound 2.6.1)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286612(US9566312, Compound 2.19.8)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286551(US9566312, Compound 2.5.32)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286592(US9566312, Compound 2.17.10)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286609(US9566312, Compound 2.19.5)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286585(US9566312, Compound 2.17.3)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286570(US9566312, Compound 2.8.9)
Affinity DataKd:  0.400nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM50030555(CHEMBL3344493 | US9566312, Compound 2.10)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286591(US9566312, Compound 2.17.9)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Novartis

US Patent
LigandPNGBDBM286543(US9566312, Compound 2.5.24)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286592(US9566312, Compound 2.17.10)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286572(US9566312, Compound 2.8.11)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286588(US9566312, Compound 2.17.6)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286605(US9566312, Compound 2.19.1)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286605(US9566312, Compound 2.19.1)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286573(US9566312, Compound 2.9)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286557(US9566312, Compound 2.6.3)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286606(US9566312, Compound 2.19.2)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM50030555(CHEMBL3344493 | US9566312, Compound 2.10)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Novartis

US Patent
LigandPNGBDBM286596(US9566312, Compound 2.17.14)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286596(US9566312, Compound 2.17.14)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286609(US9566312, Compound 2.19.5)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase B(Human)
Novartis

US Patent
LigandPNGBDBM286528(US9566312, Compound 2.5.9)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286610(US9566312, Compound 2.19.6)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

LigandPNGBDBM286533(US9566312, Compound 2.5.15 | US9566312, Compound 2...)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

Displayed 1 to 50 (of 321 total ) | Next | Last >>
Jump to: